Macrophages  ||| S:0 E:12 ||| NNP
and  ||| S:12 E:16 ||| CC
Alcohol-Related  ||| S:16 E:32 ||| NNP
Liver  ||| S:32 E:38 ||| NNP
Inflammation  ||| S:38 E:51 ||| NNP
Recent  ||| S:51 E:58 ||| JJ
studies  ||| S:58 E:66 ||| NNS
have  ||| S:66 E:71 ||| VBP
suggested  ||| S:71 E:81 ||| VBN
that  ||| S:81 E:86 ||| IN
macrophages  ||| S:86 E:98 ||| NNS
have  ||| S:98 E:103 ||| VBP
a  ||| S:103 E:105 ||| DT
critical  ||| S:105 E:114 ||| JJ
role  ||| S:114 E:119 ||| NN
in  ||| S:119 E:122 ||| IN
the  ||| S:122 E:126 ||| DT
development  ||| S:126 E:138 ||| NN
of  ||| S:138 E:141 ||| IN
alcohol-induced  ||| S:141 E:157 ||| JJ
inflammation  ||| S:157 E:170 ||| NN
in  ||| S:170 E:173 ||| IN
the  ||| S:173 E:177 ||| DT
liver ||| S:177 E:182 ||| NN
.  ||| S:182 E:184 ||| .
To  ||| S:184 E:187 ||| TO
define  ||| S:187 E:194 ||| VB
the  ||| S:194 E:198 ||| DT
precise  ||| S:198 E:206 ||| JJ
pathogenic  ||| S:206 E:217 ||| JJ
function  ||| S:217 E:226 ||| NN
of  ||| S:226 E:229 ||| IN
these  ||| S:229 E:235 ||| DT
cells  ||| S:235 E:241 ||| NNS
during  ||| S:241 E:248 ||| IN
alcoholic  ||| S:248 E:258 ||| JJ
liver  ||| S:258 E:264 ||| NN
disease  ||| S:264 E:272 ||| NN
( ||| S:272 E:273 ||| -LRB-
ALD ||| S:273 E:276 ||| NNP
) ||| S:276 E:277 ||| -RRB-
,  ||| S:277 E:279 ||| ,
it  ||| S:279 E:282 ||| PRP
is  ||| S:282 E:285 ||| VBZ
extremely  ||| S:285 E:295 ||| RB
important  ||| S:295 E:305 ||| JJ
to  ||| S:305 E:308 ||| TO
conduct  ||| S:308 E:316 ||| VB
extensive  ||| S:316 E:326 ||| JJ
studies  ||| S:326 E:334 ||| NNS
in  ||| S:334 E:337 ||| IN
clinical  ||| S:337 E:346 ||| JJ
settings  ||| S:346 E:355 ||| NNS
that  ||| S:355 E:360 ||| WDT
further  ||| S:360 E:368 ||| RB
elucidate  ||| S:368 E:378 ||| VB
the  ||| S:378 E:382 ||| DT
phenotypic  ||| S:382 E:393 ||| JJ
diversity  ||| S:393 E:403 ||| NN
of  ||| S:403 E:406 ||| IN
macrophages  ||| S:406 E:418 ||| NN
In  ||| S:418 E:421 ||| IN
the  ||| S:421 E:425 ||| DT
context  ||| S:425 E:433 ||| NN
of  ||| S:433 E:436 ||| IN
ALD ||| S:436 E:439 ||| NNP
.  ||| S:439 E:441 ||| .
Research  ||| S:441 E:450 ||| NN
to  ||| S:450 E:453 ||| TO
date  ||| S:453 E:458 ||| VB
already  ||| S:458 E:466 ||| RB
has  ||| S:466 E:470 ||| VBZ
identified  ||| S:470 E:481 ||| VBN
several  ||| S:481 E:489 ||| JJ
characteristics  ||| S:489 E:505 ||| NNS
of  ||| S:505 E:508 ||| IN
macrophages  ||| S:508 E:520 ||| NNS
that  ||| S:520 E:525 ||| WDT
underlie  ||| S:525 E:534 ||| VBZ
the  ||| S:534 E:538 ||| DT
cells ||| S:538 E:543 ||| NNS
'  ||| S:543 E:545 ||| POS
actions ||| S:545 E:552 ||| NNS
,  ||| S:552 E:554 ||| ,
including  ||| S:554 E:564 ||| VBG
macrophage  ||| S:564 E:575 ||| JJ
polarization  ||| S:575 E:588 ||| NN
and  ||| S:588 E:592 ||| CC
their  ||| S:592 E:598 ||| PRP$
phenotypic  ||| S:598 E:609 ||| JJ
diversity ||| S:609 E:618 ||| NN
.  ||| S:618 E:620 ||| .
Other  ||| S:620 E:626 ||| JJ
analyses  ||| S:626 E:635 ||| NNS
have  ||| S:635 E:640 ||| VBP
focused  ||| S:640 E:648 ||| VBN
on  ||| S:648 E:651 ||| IN
the  ||| S:651 E:655 ||| DT
contributions  ||| S:655 E:669 ||| NNS
of  ||| S:669 E:672 ||| IN
resident  ||| S:672 E:681 ||| FW
versus  ||| S:681 E:688 ||| FW
infiltrating  ||| S:688 E:701 ||| FW
macrophages ||| S:701 E:712 ||| FW
/ ||| S:712 E:713 ||| FW
monocytes ||| S:713 E:722 ||| FW
,  ||| S:722 E:724 ||| ,
as  ||| S:724 E:727 ||| RB
well  ||| S:727 E:732 ||| RB
as  ||| S:732 E:735 ||| RB
on  ||| S:735 E:738 ||| IN
the  ||| S:738 E:742 ||| DT
roles  ||| S:742 E:748 ||| NNS
of  ||| S:748 E:751 ||| IN
macrophage  ||| S:751 E:762 ||| JJ
mediators ||| S:762 E:771 ||| NNS
,  ||| S:771 E:773 ||| ,
in  ||| S:773 E:776 ||| IN
the  ||| S:776 E:780 ||| DT
development  ||| S:780 E:792 ||| NN
of  ||| S:792 E:795 ||| IN
ALD ||| S:795 E:798 ||| NNP
.  ||| S:798 E:800 ||| .
Findings  ||| S:800 E:809 ||| NNS
point  ||| S:809 E:815 ||| VBP
to  ||| S:815 E:818 ||| TO
the  ||| S:818 E:822 ||| DT
potential  ||| S:822 E:832 ||| NN
of  ||| S:832 E:835 ||| IN
macrophages  ||| S:835 E:847 ||| NN
as  ||| S:847 E:850 ||| IN
a  ||| S:850 E:852 ||| DT
therapeutic  ||| S:852 E:864 ||| JJ
target  ||| S:864 E:871 ||| NN
in  ||| S:871 E:874 ||| IN
alcoholic  ||| S:874 E:884 ||| JJ
liver  ||| S:884 E:890 ||| NN
injury ||| S:890 E:896 ||| NN
.  ||| S:896 E:898 ||| .
Future  ||| S:898 E:905 ||| JJ
studies  ||| S:905 E:913 ||| NNS
directed  ||| S:913 E:922 ||| VBN
toward  ||| S:922 E:929 ||| IN
understanding  ||| S:929 E:943 ||| NN
how  ||| S:943 E:947 ||| WRB
alcohol  ||| S:947 E:955 ||| NN
affects  ||| S:955 E:963 ||| VBZ
macrophage  ||| S:963 E:974 ||| JJ
phenotypic  ||| S:974 E:985 ||| JJ
switch  ||| S:985 E:992 ||| NN
in  ||| S:992 E:995 ||| IN
the  ||| S:995 E:999 ||| DT
liver  ||| S:999 E:1005 ||| NN
and  ||| S:1005 E:1009 ||| CC
other  ||| S:1009 E:1015 ||| JJ
tissues ||| S:1015 E:1022 ||| NNS
,  ||| S:1022 E:1024 ||| ,
whether  ||| S:1024 E:1032 ||| IN
the  ||| S:1032 E:1036 ||| DT
liver  ||| S:1036 E:1042 ||| JJ
microenvironment  ||| S:1042 E:1059 ||| NN
determines  ||| S:1059 E:1070 ||| VBZ
macrophage  ||| S:1070 E:1081 ||| JJ
function  ||| S:1081 E:1090 ||| NN
in  ||| S:1090 E:1093 ||| IN
ALO  ||| S:1093 E:1097 ||| NNP
and  ||| S:1097 E:1101 ||| CC
if  ||| S:1101 E:1104 ||| IN
targeting  ||| S:1104 E:1114 ||| VBG
of  ||| S:1114 E:1117 ||| IN
macrophages  ||| S:1117 E:1129 ||| FW
alleviates  ||| S:1129 E:1140 ||| FW
alcoholic  ||| S:1140 E:1150 ||| FW
liver  ||| S:1150 E:1156 ||| FW
injury ||| S:1156 E:1162 ||| FW
,  ||| S:1162 E:1164 ||| ,
will  ||| S:1164 E:1169 ||| MD
provide  ||| S:1169 E:1177 ||| VB
promising  ||| S:1177 E:1187 ||| JJ
strategies  ||| S:1187 E:1198 ||| NNS
to  ||| S:1198 E:1201 ||| TO
manage  ||| S:1201 E:1208 ||| VB
patients  ||| S:1208 E:1217 ||| NNS
with  ||| S:1217 E:1222 ||| IN
alcoholic  ||| S:1222 E:1232 ||| JJ
hepatitis ||| S:1232 E:1241 ||| NN
.  ||| S:1241 E:1243 ||| .
